298 related articles for article (PubMed ID: 32664824)
1. The new simplified MARIA score applies beyond clinical trials: A suitable clinical practice tool for Crohn's disease that parallels a simple endoscopic index and fecal calprotectin.
Roseira J; Ventosa AR; de Sousa HT; Brito J
United European Gastroenterol J; 2020 Dec; 8(10):1208-1216. PubMed ID: 32664824
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn's disease.
Somwaru AS; Khanijow V; Katabathina VS
BMC Gastroenterol; 2019 Dec; 19(1):210. PubMed ID: 31805875
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
4. Fecal Calprotectin in Ileal Crohn's Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score.
Cerrillo E; Beltrán B; Pous S; Echarri A; Gallego JC; Iborra M; Pamies J; Nos P
Inflamm Bowel Dis; 2015 Jul; 21(7):1572-9. PubMed ID: 26052967
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
[TBL] [Abstract][Full Text] [Related]
6. Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn's Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography.
Arai T; Takeuchi K; Miyamura M; Ishikawa R; Yamada A; Katsumata M; Igarashi Y; Suzuki Y
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):56-62. PubMed ID: 27565523
[TBL] [Abstract][Full Text] [Related]
7. Validation of the simplified magnetic resonance index of activity by using DWI without gadolinium enhancement to evaluate bowel inflammation in Crohn's disease.
Bae H; Seo N; Kang EA; Cheon JH; Lim JS; Kim MJ
Eur Radiol; 2023 May; 33(5):3266-3275. PubMed ID: 36899087
[TBL] [Abstract][Full Text] [Related]
8. Can the simplified magnetic resonance index of activity be used to evaluate the degree of activity in Crohn's disease?
Tao Y; Li H; Xu H; Tang W; Fan G; Yang X
BMC Gastroenterol; 2021 Oct; 21(1):409. PubMed ID: 34711180
[TBL] [Abstract][Full Text] [Related]
9. Impact of disease location on fecal calprotectin levels in Crohn's disease.
Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
[TBL] [Abstract][Full Text] [Related]
10. Avoiding contrast-enhanced sequences does not compromise the precision of the simplified MaRIA for the assessment of non-penetrating Crohn's disease activity.
Fernàndez-Clotet A; Sapena V; Capozzi N; Rodríguez S; Masamunt MC; Ricart E; Ordás I; Panés J; Rimola J
Eur Radiol; 2022 May; 32(5):3334-3345. PubMed ID: 35031844
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the magnetic resonance scoring systems for Crohn's disease activity: MaRIA, simplified MaRIA, and Nancy scores.
Lee WE; Weng MT; Wei SC; Shih IL
Abdom Radiol (NY); 2023 Jul; 48(7):2228-2236. PubMed ID: 37129624
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin.
Makanyanga JC; Pendsé D; Dikaios N; Bloom S; McCartney S; Helbren E; Atkins E; Cuthbertson T; Punwani S; Forbes A; Halligan S; Taylor SA
Eur Radiol; 2014 Feb; 24(2):277-87. PubMed ID: 24026620
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of sonographic activity scores for adult terminal ileal Crohn's disease compared to magnetic resonance and histological reference standards: experience from the METRIC trial.
Kumar S; Parry T; Mallett S; Plumb A; Bhatnagar G; Beable R; Betts M; Duncan G; Gupta A; Higginson A; Hyland R; Lapham R; Patel U; Pilcher J; Slater A; Tolan D; Zealley I; Halligan S; Taylor SA;
Eur Radiol; 2024 Jan; 34(1):455-464. PubMed ID: 37526665
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn's Disease.
Capozzi N; Ordás I; Fernandez-Clotet A; Castro-Poceiro J; Rodríguez S; Alfaro I; Sapena V; Masamunt MC; Ricart E; Panés J; Rimola J
J Crohns Colitis; 2020 Sep; 14(8):1074-1081. PubMed ID: 32080712
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.
Baillet P; Cadiot G; Goutte M; Goutorbe F; Brixi H; Hoeffel C; Allimant C; Reymond M; Obritin-Guilhen H; Magnin B; Bommelaer G; Pereira B; Hordonneau C; Buisson A
World J Gastroenterol; 2018 Feb; 24(5):641-650. PubMed ID: 29434453
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
D'Haens G; Kelly O; Battat R; Silverberg MS; Laharie D; Louis E; Savarino E; Bodini G; Yarur A; Boland BS; Afif W; Li XJ; Hale M; Ho J; Kondragunta V; Huang B; Kuy C; Okada L; Hester KD; Bray KR; Mimms L; Jain A; Singh S; Collins A; Valasek MA; Sandborn WJ; Vermeire S; Dulai PS
Gastroenterology; 2020 Feb; 158(3):515-526.e10. PubMed ID: 31711925
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
18. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
20. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
Zubin G; Peter L
Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
